Leng, H., & Simon, K. (2019). Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease.
Lua i Stíl Chicago (17ú heag.)Leng, H., agus K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.
Lua MLA (9ú heag.)Leng, H., agus K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.